📰 Evidence Development News
Page 5 - Evidence Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evidence Development. Real-time updates on events, politics, business and more.
December 20, 2022
Association Files Formal Request for Reconsideration of National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the...
December 5, 2022
Congressman John Joyce, M.D. (PA-13) and Congresswoman Nanette Barragán (CA-44), recently introduced legislation to ensure greater access to Alzheimer’s Disease treatments for American seniors.
April 14, 2022
On April 7, the Centers for Medicare & Medicaid Services (CMS) released its highly anticipated final National Coverage Determination (NCD) for Aduhelm and other similar therapies in the...
April 7, 2022
Medicare finalized its plan to restrict coverage for a controversial, pricey Alzheimer’s drug to patients participating in clinical trials.
April 4, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are...
March 31, 2022
NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”)...
March 31, 2022
Renee Kinder Observe a therapist for a day and you will likely note among their communication is full of alphabet soup and acronyms. ICD-10, CPT, HIPPS,
March 17, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are...
March 17, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are...
March 9, 2022
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are...